New FDA designations granted to NCATS for rare disease therapies. NCBI
Originally posted here:
New FDA designations granted to NCATS for rare disease therapies. - NCBI
University of Arkansas Researcher Awarded $1.8M for Gene Therapy Study Arkansas Business
Read more here:
University of Arkansas Researcher Awarded $1.8M for Gene Therapy Study - Arkansas Business
$1.8 Million Awarded to Study the Durability of Gene Therapy University of Arkansas Newswire
Read more:
$1.8 Million Awarded to Study the Durability of Gene Therapy - University of Arkansas Newswire
By the numbers: US leads charge of cell and gene therapies BioWorld Online
See the original post:
By the numbers: US leads charge of cell and gene therapies - BioWorld Online
See the rest here:
Cellectis to Present Data on TALE-Base Editors and Non-Viral Gene Therapy at the ESGCT 31st Annual Congress - StockTitan
Around the Helix: Cell and Gene Therapy Company Updates October 16, 2024 CGTLive
Read more:
Around the Helix: Cell and Gene Therapy Company Updates October 16, 2024 - CGTLive
A New Type of Gene Therapy Shows Promise for Treating Retinitis Pigmentosa Managed Healthcare Executive
View original post here:
A New Type of Gene Therapy Shows Promise for Treating Retinitis Pigmentosa - Managed Healthcare Executive
Japan mulls ways to boost cell, gene therapy approvals BioWorld Online
View post:
Japan mulls ways to boost cell, gene therapy approvals - BioWorld Online
When a Miracle Cure Is Left on the Shelf Bloomberg
Genethon to Showcase the Latest Advances in Gene Therapies for Multiple Diseases at the ESGCT 31 Business Wire
Originally posted here:
Genethon to Showcase the Latest Advances in Gene Therapies for Multiple Diseases at the ESGCT 31 - Business Wire
Buy, Sell, Hold: Cell and Gene Therapy - Part 2 BioPharm International
Go here to read the rest:
Buy, Sell, Hold: Cell and Gene Therapy - Part 2 - BioPharm International
MeiraGTx's gene therapy improves motor function and quality of life in phase 2 Parkinson's trial Fierce Biotech
See the article here:
MeiraGTx's gene therapy improves motor function and quality of life in phase 2 Parkinson's trial - Fierce Biotech
5 Sickle Cell Therapies to Watch Following Pfizers Oxbryta Exit BioSpace
Excerpt from:
5 Sickle Cell Therapies to Watch Following Pfizers Oxbryta Exit - BioSpace
Fiocruz and GEMMABio announce partnership for the development of gene therapies Fiocruz
More here:
Fiocruz and GEMMABio announce partnership for the development of gene therapies - Fiocruz
The rest is here:
JPMA on Japans Biotech Industry: Cancer, Cardiovascular, and Aging Lead Diseases; Antibody, Cell, and Gene Therapies Top the Innovation List -...
Cell and Gene Therapy Clinical Trial Market is expected to reach USD 119.3 Billion by 2032 at a 24.9% of CAGR PharmiWeb.com
View original post here:
Cell and Gene Therapy Clinical Trial Market is expected to reach USD 119.3 Billion by 2032 at a 24.9% of CAGR - PharmiWeb.com
Buy, Sell, Hold: Cell and Gene Therapy - Part 3 Pharmaceutical Technology Magazine
See the original post here:
Buy, Sell, Hold: Cell and Gene Therapy - Part 3 - Pharmaceutical Technology Magazine
The role of quality assurance in accelerating drug development for emerging therapies pharmaphorum
Here is the original post:
The role of quality assurance in accelerating drug development for emerging therapies - pharmaphorum
Nucleic Acid and Gene Therapies in Neuromuscular Disorders Market is projected to grow at a CAGR of PharmiWeb.com
Cellectis to Present Data on TALE-Base Editors and Non-Viral Gene Therapy at the ESGCT 31st Annual Congress The Manila Times
Go here to read the rest:
Cellectis to Present Data on TALE-Base Editors and Non-Viral Gene Therapy at the ESGCT 31st Annual Congress - The Manila Times